BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $538,000 | +33.2% | 417,433 | +8.6% | 0.01% | +55.6% |
| Q3 2019 | $404,000 | -81.5% | 384,427 | -70.1% | 0.01% | -83.6% |
| Q2 2019 | $2,184,000 | -53.0% | 1,284,955 | -6.9% | 0.06% | -58.6% |
| Q1 2019 | $4,649,000 | +54.0% | 1,379,629 | +33.5% | 0.13% | +8.1% |
| Q4 2018 | $3,018,000 | -17.0% | 1,033,491 | +75.1% | 0.12% | +11.8% |
| Q3 2018 | $3,636,000 | +73.6% | 590,214 | +108.0% | 0.11% | +42.9% |
| Q2 2018 | $2,094,000 | – | 283,772 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |